---
title: 'Scientist / Senior Scientist, Computational Biology at Precede'
canonical: 'https://feeny.ai/job/scientist-senior-scientist-computational-biology-precede-boston-m9pf6akf73sj'
type: 'job'
last_seen: '2026-11-04'
---

# Scientist / Senior Scientist, Computational Biology at Precede

- **Company:** Precede
- **Location:** Boston, MA
- **Compensation:** $125k–$175k
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-11-02
- **Last confirmed live:** 2026-11-04
- **Apply:** https://jobs.lever.co/precede/5adc9a8c-1059-4307-9dac-8036ddf10433

## Job description

## About Precede Biosciences

We are pioneering an advanced, minimally invasive, comprehensive epigenomics platform with the potential to profoundly impact the research and development of new medicines and the use of approved medicines in clinical practice across a number of conditions, including cancer. More information on our company and platform can be found on our company website and in our seminal publication in Nature Medicine.

We care deeply about creating a place where folks can do their best work from the start and have intentionally created an environment that is defined by purpose, teamwork, and excellence. This means nurturing team spirit, facing challenges together, collaboratively solving complex problems, while also ensuring a strong focus on individual initiative, accountability, and delivery.

## The Role

This role involves formulating computational methods and conducting interpretative analyses integral to a variety of biopharma R&D applications and diagnostic applications. This is a unique opportunity for someone passionate about innovating methodologies and unearthing groundbreaking biology in a setting where computational biology is key. If you're intrigued by the prospect of joining an early-stage company with an experienced team operating at a rapid pace, this could be your perfect match.

## Responsibilities

- You will blend biological insights with computational techniques to develop predictive models with immediate clinical applications.
- You will lead projects that bridge the biological understanding of disease-relevant systems with computational analyses to drive diagnostic innovation.
- Working with a skilled team of computational biologists, you will spearhead the analysis of novel epigenomic data and refine its clinical impact.
- You will explore the biological underpinnings of numerous disease areas to produce biologically informed analyses that demonstrate significant endpoints.
- Additionally, you will create novel classifiers with diagnostic relevance suitable for clinical use.
- As a key member of a cross-functional team that encompasses clinical, translational, computational, and product development, you will collaborate with various stakeholders to make innovative diagnostics a reality.

## Qualifications

- You have experience in using computational analyses of the epigenome to weave a compelling biological narrative.
- You are comfortable presenting this narrative in a group setting.
- All levels of experience are encouraged to apply, and the role will be set commensurate with your experience.
- You are excited by challenging problems and a fast-paced work environment.
- You thrive in startup culture, comfortable taking on new projects with minimal direction, and are adaptive in response to feedback and evolving information.
- You are proficient in either R (Bioconductor) or Python.
- You value diversity, learning from various perspectives, and working collaboratively on multidisciplinary teams.

We believe in building an inclusive and balanced team. We also know meeting every single-exact-criteria can get in the way of meeting stellar folks. Please don’t hesitate to apply!

Precede Biosciences is an equal opportunity employer. We do not discriminate in regard to race, color, religion, national origin, age, sex, sexual orientation, gender identity, marital status, ancestry, physical or mental disability, veteran status, or any other legally protected.

Please note that we do not accept unsolicited resumes from recruitment agencies and external recruiters. No fees will be paid for such submissions.

## About Precede

## Company Overview
- **One-liner**: Precede Biosciences decodes genome-wide transcriptional biology from a simple blood test to enable precision medicine and accelerate drug development.
- **Entity Type**: Private (Series B)
- **Headquarters**: Boston, Massachusetts, United States
- **Founded**: 2021
- **Founders**: Rehan Verjee (CEO)

## Core Business
- **Primary industry**: Biotechnology / Precision Diagnostics
- **Target customers**: Biopharmaceutical companies (drug developers), clinical researchers, and diagnostic partners (B2B)
- **Mission or purpose**: To create a world where new medicine development succeeds more frequently and where anyone can receive a minimally invasive diagnosis and treatment precise to the biology of their disease.

## Products & Services
- **Precede Bio Insight™**: A first-of-its-kind liquid biopsy product that profiles circulating chromatin and the DNA methylome from just 1 mL of plasma. It enables quantitative inference of gene expression, pathway activity, and cell states – providing a functional, systems-level view of tumor biology. Used for therapeutic target discovery, patient selection, and understanding treatment resistance. (SaaS-like platform service for biopharma partners)
- **Custom Diagnostic Development**: Partnering with medicine developers to design and validate diagnostic tests that reveal target expression and pathway biology relevant to next-generation precision medicines (e.g., ADCs, protein degraders).

## Market Standing
- **Valuation/Market Cap**: Not publicly disclosed. Total funding raised: **$140.5M** (as of January 2026).
- **Key Metric**: Total funding of $140.5M across Series A, Series B, and debt financing. Estimated annual revenue of ~$8M (third-party estimate).
- **Notable Investors/Partners**: 5AM Ventures, Lilly Asia Ventures, Illumina Ventures, Bristol Myers Squibb, Osage University Partners, Binney Street Capital, Labcorp Venture Fund, UPMC Enterprises, Mirae Asset Capital Life Science, 28 Capital LLC, Alexandria Venture Investments. Strategic partnership with SVB for non-dilutive financing.
- **Growth Signals**: 55 employees (+17.3% YoY); 4 active job postings; launched Precede Bio Insight™ in April 2026; strong commercial traction with leading biopharma developers; presented data at major conferences (ESMO 2024, ASCO 2024, ECTRIMS 2024).

## Competitive Advantages
- **Unique platform**: Profiles circulating chromatin and DNA methylome at genome-wide scale (~20K gene promoters, ~1M enhancers, ~50K CpG islands) from a single 1 mL blood sample, providing resolution into individual gene and pathway activation that tissue biopsies cannot easily capture.
- **Actionable readouts**: Uses proprietary machine learning to deliver interpretable, quantitative data on therapeutic targets, resistance pathways, and tumor lineage – directly relevant to next-generation precision medicines.
- **Minimally invasive**: Simple blood draw replaces invasive tissue biopsies, enabling longitudinal monitoring and broader patient access.

## Strategic Focus
- Scale the Precede Bio Insight™ platform for broader biopharma adoption.
- Expand partnerships with drug developers to co-develop companion diagnostics.
- Advance internal diagnostic tests for specific oncology indications.
- Continue building a world-class team in computational biology, epigenomics, and translational sciences.

## Why Work Here
- **Mission-driven**: Tackle hard problems in precision medicine with a team that values trust, collaboration, and impact.
- **Hybrid work**: Offices in Boston, MA (1 Design Center Place) with hybrid flexibility for most roles.
- **Small but growing**: 55 employees with a flat structure – every person has the potential to shape the company.
- **Culture**: Emphasis on mutual care, intellectual curiosity, and a “one team” mentality. Recent job postings include roles in computational test development, project management, and translational oncology.
- **Perks**: Not explicitly listed, but the environment is typical of a well-funded biotech startup with opportunities for rapid growth and influence.

## Sources
1. [precede.bio](https://www.precede.bio/)
2. [jobs.lever.co/precede](https://jobs.lever.co/precede)
3. [linkedin.com/company/precedebiosciences](https://linkedin.com/company/precedebiosciences)
4. [cbinsights.com/company/precede-biosciences](https://www.cbinsights.com/company/precede-biosciences)
5. [builtin.com/company/precede-biosciences](https://builtin.com/company/precede-biosciences)

## Other roles at Precede

- [Associate Director, Alliance and Project Management](https://feeny.ai/job/associate-director-alliance-and-project-management-precede-cambridge-zftv1qwegjaj) — Cambridge, MA
- [Associate Director/Director, Computational Test Development](https://feeny.ai/job/associate-director-director-computational-test-development-precede-cambridge-vax7530xbk3b) — Cambridge, MA
- [Associate Director, Regulatory Affairs (IVD)](https://feeny.ai/job/associate-director-regulatory-affairs-ivd-precede-cambridge-aj3fke22z1rx) — Cambridge, MA
- [Associate Scientist / Scientist I, Computational Test Development](https://feeny.ai/job/associate-scientist-scientist-i-computational-test-development-precede-boston-c7pmhcxnr9pt) — Boston, MA